Dublin, July 22, 2025 (GLOBE NEWSWIRE) -- The "Lennox Gastaut Syndrome Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's ...

Please provide your email address to receive an email when new articles are posted on . “Most patients with [Lennox-Gastaut syndrome (LGS)] develop between three and five seizure types that wax and ...

Please provide your email address to receive an email when new articles are posted on . Children with Lennox Gastaut and Dravet have a higher mortality risk than adults. Those with higher health care ...

New York, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Lennox Gastaut Syndrome – Market Insights, Epidemiology, and ...

A Takeda Pharmaceutical drug in development for rare forms of epilepsy that are resistant to anti-seizure medications has failed to meet the main goals of two placebo-controlled pivotal studies, a ...

For more information, visit LGS-CORE Study. The Lennox-Gastaut Syndrome (LGS) Foundation is a nonprofit organization dedicated to improving the lives of individuals impacted by LGS. It educates the ...

BOHEMIA, N.Y., Dec. 3, 2020 /PRNewswire/ -- The Lennox-Gastaut Syndrome (LGS) Foundation is pleased to announce that Dr. Tracy Dixon-Salazar is now the new Executive Director of the LGS Foundation.

SANTA BARBARA COUNTY, Calif. – The Lennox-Gastaut Syndrome (LGS) Foundation held its 7th annual Walk 'n' Wheel in Santa Barbara to raise awareness of the condition and increase funding for research.

DUBLIN--(BUSINESS WIRE)--The "Lennox Gastaut Syndrome - Epidemiology Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. Lennox Gastaut Syndrome - Epidemiology Forecast to ...

LONDON--(BUSINESS WIRE)--The global Lennox-Gastaut syndrome (LGS) treatment market is expected to post a CAGR of close to 5% during the period 2019-2023, according to the latest market research report ...